Mr. Andrew Teggert, Clinical Scientist, James Cook University Hospital with SIEMENS ADVIA Chemistry XPT BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 An interview with Mr. Andrew Teggert, Clinical Scientist, James Cook University Hospital, Middlesbrough. At the largest hospital in Tees Valley,
Continue Reading
BUHLMANN News
BUHLMANN Diagnostics Corp is proud to release the sixth edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Check Out LabSense News Today! What's New Introducing BAT in Food Allergy Webinar recording and eBook by Dr. Alexandra Santos as well as two new IBDoc® Posters
Continue Reading
Health Canada Licence: 98903, Device class: 3 IBDoc® is not available for sale in the US. IBDoc® Calprotectin Home Test Video IBDoc® Highlights Learn more about this calprotectin home test and check out the IBDoc® highlights including key features, studies, posters, citations, videos, informational flyers and more! Three Easy Steps to Help Monitor IBD IBDoc® is the first
Continue Reading
Technical Details Speed An immunoturbidimetric assay (or particle-enhanced turbidimetric immunoassay (PETIA)) for measuring Calprotectin is the fastest solution in the market with the shortest time to first result regardless of using sample batches or random access. On average, the time to first result is 7.6 min [5 min -11.6 min] with additional results every 10.86
Continue Reading
BÜHLMANN fCAL® Assays BÜHLMANN fCAL® Assays have rock-solid performance that provide you with optimal precision to measure your results. Focus on what really matters - calprotectin results you can stand behind. Increase your efficiency and cost savings with BÜHLMANN fCAL® turbo, BÜHLMANN fCAL® ELISA, and Quantum Blue® fCAL. Precision & Linearity Data LEARN MORE Success Stories BÜHLMANN's calprotectin assays success stories
Continue Reading
BAT Relevant Literature: Santos AF, Douiri A, Bécares N, Wu SY, Stephens A, Radulovic S, Chan SM, Fox AT, Du Toit G, Turcanu V, Lack G. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. J Allergy Clin Immunol. 2014 Sep;134(3):645-52. PMID: 25065721 doi: 10.1016/j.jaci.2014.04.039. Highlights from this Publication “BAT proved to be superior to
Continue Reading
BAT Relevant Literature: Ponce M, Diesner SC, Szépfalusi Z, Eiwegger T. Markers of tolerance development to food allergens. Allergy. 2016 Oct;71(10):1393-404. Epub 2016 Jul 11. Review. PMID: 27286276 DOI: 10.1111/all.12953 Highlights from this Publication “Biomarkers that predict tolerance development as compared to desensitization are needed. This is decisive to consult patients on treatment duration and risk behavior if OIT
Continue Reading
BAT Relevant Literature: Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo DG, Sabato V, Sanz ML, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015 Nov;70(11):1393-405. Epub 2015 Sep
Continue Reading
BAT Relevant Literature: Santos AF, Brough HA. Making the Most of In Vitro Tests to Diagnose Food Allergy. J Allergy Clin Immunol Pract. 2017 Mar - Apr;5(2):237-248. PMID: 28283150 DOI: 10.1016/j.jaip.2016.12.003. Highlights from this Publication “Various in vitro tests assess different aspects of the underlying immune mechanism of IgE-mediated food allergy. Some can be used for diagnostic
Continue Reading
BAT Relevant Literature: Santos AF, Shreffler WG. Road map for the clinical application of the basophil activation test in food allergy. Clin Exp Allergy. 2017 Sep;47(9):1115-1124. doi: 10.1111/cea.12964. Epub 2017 Aug 1. Review. PubMed PMID: 28618090 DOI: 10.1111/cea.12964 . Highlights from this Publication “..BAT is sensitive and more specific than standard testing and has the potential to reduce
Continue Reading
